StockClub

ARDS

ARDSAridis Pharmaceuticals, Inc.$ --
Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc.

ARDS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2023FY2023 Q3
Revenue
0M USD
YoY +Infinity%
Operating Income
-1M USD
YoY +88.3%
Net Income
-0M USD
YoY +99.1%
EPS
-0$
YoY +99.6%

Revenue

$20.1M
FY2021 Q4$701,000
$701,000
Q4
FY2022 Q1$0
$0
Q1
FY2022 Q2$292,000
$292,000
Q2
FY2022 Q3$292,000
$292,000
Q3
FY2022 Q4$292,000
$292,000
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$19.6M
$19.6M
Q2
FY2023 Q3$20.1M
$20.1M
Q3
Actual
+$19.8M (+6771.2%)

Net Income

$5.2M
FY2021 Q4$-43.6M
$-43.6M
Q4
FY2022 Q1$-8.1M
$-8.1M
Q1
FY2022 Q2$-16.3M
$-16.3M
Q2
FY2022 Q3$-25.4M
$-25.4M
Q3
FY2022 Q4$-31.8M
$-31.8M
Q4
FY2023 Q1$-6.8M
$-6.8M
Q1
FY2023 Q2$5.3M
$5.3M
Q2
FY2023 Q3$5.2M
$5.2M
Q3
Actual
+$30.6M (+120.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017
Actual:$860,000
FY2017
$860,000
FY2018BEAT
Actual:$2.8M
Est:$1.7M
FY2018BEAT
$2.8M
FY2019MISS
Actual:$1M
Est:$1.3M
FY2019MISS
$1M
FY2020MISS
Actual:$1M
Est:$1.5M
FY2020MISS
$1M
FY2021MISS
Actual:$0
Est:$2.4M
FY2021MISS
$0
FY2022MISS
Actual:$0
Est:$2.2M
FY2022MISS
$0

Analyst Estimates